News
Article Published: May 1998 Molecular genetics of human retinal dystrophies Chris F Inglehearn Eye 12, 571–579 (1998) Cite this article ...
Roche's Genentech unit has won FDA approval for Susvimo, an implant for eyesight-robbing disease wet age-related macular degeneration (AMD) that gives patients an alternative to regular injections ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback